Let's get genomical

Each of us carries a treasure-trove of information about our ancestors in the form of DNA. For a little bit of saliva and a not-so-little bit of cash, numerous direct-to-consumer genetic services now offer people an insight into their ancestry. With a scientist’s eye, I'll talk about what DNA can (and can't) tell us about the ghosts of our ancestors - not just as individuals, but as populations of people with a lively history of migration, isolation, and mixture.

Every gene in your genome is a potential drug target, and every mutation a potential drug. We each play host to thousands of naturally-occurring drug trials: subtle genetic differences that change the way our bodys work. Some of us are testing a "drug" that helps to maintain a healthy body weight. Others are testing a "drug" that reduces the risk of heart disease. Come and learn how we use genetics - nature's clinical trial - to guide real drug discovery, and how an electronic health record can help to avoid serious side effects.

Identification of disease risk, design of targeted therapies and prediction of drug response have all been enabled by genomics. This progress has resulted in growing optimism that genomics has the potential to revolutionise healthcare. However, due to existing inequalities in health systems, genomics is in fact at risk of perpetuating disparities. Research already suggests a lack of representation for minority ethnic groups in genomic research. This talk will discuss the scientific imperative and the issues of social justice that underpin the need for increased diversity in genomic research.

As part of the Creative Reactions project, these artists will be presenting their artwork inspired by the research of speakers in this talk series. The artwork will also be on display at our Creative Reactions Exhibition at St Barnabas Church, 24 - 25 May.